Expression and activity of methionine cycle genes are altered following folate and vitamin E deficiency under oxidative challenge: Modulation by apolipoprotein E-deficiency

References

• Arrula VR, von Zuben PM, Chaiparini LC, Annichino-Bizzachi JM, Costa FF. 1997. The mutation Ala677-Val in the methylene tetrohydrofolate reductase gene: A risk factor for arterial disease and venous thrombosis. Thrombo Haemost 77:818–821.
   PubMed Web of Science ®Google Scholar
• Bertrand P, Poirier J, Oda T, Finch CE, Pasinetti GM. 1995. Association of apolipoprotein E genotype with brain levels of apolipoprotein E and apolipoprotein J (clusterin) in Alzheimer disease. Mol Brain Res 33:174–178.
   PubMedGoogle Scholar
• Bottiglieri T, Godfrey P, Flynn T, Carney MW, Toone BK, Reynolds EH. 1990. Cerebrospinal fluid S-adenosylmethionine in depression and dementia: Effects of treatment with parenteral and oral S-adenosylmethionine. J Neurol Neurosurg Psychiatry 53:1096–1098.
   PubMed Web of Science ®Google Scholar
• Brunelli T, Bagnoli S, Giusti B, Nacmias B, Pepe G, Sorbi S, Abbate R. 2001. The C677T methylenetetrahydrofolate reductase mutation is not associated with Alzheimer’s disease. Neurosci Lett 315:103–105.
   PubMed Web of Science ®Google Scholar
• Burzynski SR. 2005. Aging: Gene silencing or gene activation? Med Hypotheses 64:201–208.
   PubMed Web of Science ®Google Scholar
• Chomczynski P, Sacchi N. 1999. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156–159.
   Google Scholar
• Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA. 1993. Gene dose of apolipoprotein E type e4 allele and the risk of Alzheimer’s disease in late onset families. Science 261:921–923.
   PubMed Web of Science ®Google Scholar
• Djurhuus R, Svardal AM, Ueland PM. 1989. Differential effects on growth, homocysteine and related compounds of two inhibitors of S-adenosylhomocysteine catabolism. Cancer Res 49: 124–130.
   Google Scholar
• Friso S, Girelli D, Trabetti E, Stranieri C, Olivieri O, Tinazzi E, Martinelli N, Faccini G, Pignatti PF, Corrocher R. 2002. A1298C methylenetetrahydrofolate reductase mutation and coronary artery disease: Relationships with C677T polymorphism and homocysteine/folate metabolism. Clin Exp Med 2:7–12.
   PubMed Web of Science ®Google Scholar
• Frosst P, et al. 1995. Identification of a candidate genetic risk factor for vascular disease: A common mutation at the methylenete- trahydrofolate reductase locus. Nat Genet 10:111–113.
   PubMed Web of Science ®Google Scholar
• Hardy J. 1993. Apolipoprotein E and Alzheimer’s disease. Lancet 342:737–738.
   Google Scholar
• Ho PI, Collins SC, Dhitavat S, Ortiz D, Ashline D, Rogers E, Shea TB. 2001. Homocysteine potentiates beta-amyloid neurotoxicity: Role of oxidative stress. J Neurochem 78(2):249–253, Jul.
   PubMed Web of Science ®Google Scholar
• Ho P, Ashline D, Dhitavat S, Collins S, Rogers E, Shea TB. 2003. Folate deprivation induces neurodegeneration: Roles of oxidative stress and increased homocysteine. Neurobiol Dis 14:32–42.
   PubMed Web of Science ®Google Scholar
• Huang RF, Hsu YC, Lin HL, Yang Fl. 2001. Folate depletion and elevated plasma homocysteine promote oxidative stress in rat livers. J Nutr 131:33–88.
   PubMed Web of Science ®Google Scholar
• Hyland K, Smith I, Bottiglieri T, Perry J, Wendel U, Clayton PT, Leonard JV. 1988. Demyelination and decreased S-adenosyl- methionine in 5,10-methylenetetrahydrofolate reductase deficiency. Neurology 38:459–462.
   PubMed Web of Science ®Google Scholar
• Kamboh MI. 2004. Apolipoprotein E polymorphism and susceptibility to Alzheimer’s disease. Hum Biol 67:195–215.
   Google Scholar
• Kennedy BP, Bottiglieri T, Arning E, Ziegler MG, Hansen LA, Masliah E. 2004. Elevated S-adenosylhomocysteine in Alzheimer brain: Influence on methyltransferases and cognitive function. J Neural Transm 111:547–567.
   PubMed Web of Science ®Google Scholar
• Kruman II, Culmsee C, Chan SL, Kruman Y, Guo Z, Penix L, Mattson MP. 2000. Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J Neurosci 20:6920–6926.
   PubMed Web of Science ®Google Scholar
• Kruman II, Kumaravel TS, Lohani A, Pedersen WA, Roy G, Cutler RG, Yuri K, Norman Haughey N, Lee J, Michele Evans M, Mattson MP. 2002. Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer’s disease. J Neurosci 22:1752–1762.
   PubMed Web of Science ®Google Scholar
• Liu H, Wang H, Shenvi S, Hagen TM, Liu RM. 2004. Glutathione metabolism during aging and in Alzheimer disease. Ann NY Acad Sci 1019:346–349.
   PubMed Web of Science ®Google Scholar
• Luchsinger JA, Mayeux R. 2004. Dietary factors and Alzheimer’s disease. Lancet 3:579–587.
   PubMed Web of Science ®Google Scholar
• Ma J, Stampfer MJ, Christensen B, Giovannucci E, Hunter D, Chen J, Willett WC, Selhub J, Hennekens CH, Gravel R, Rozen R. 1999. A polymorphism of the methionine synthase gene: Association with plasma folate, vitamin B12, homocyteine, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 8:825–829.
   PubMed Web of Science ®Google Scholar
• Markesbery WR, Carney JM. 1999. Oxidative alterations in Alzheimer’s disease. Brain Pathol 9:133–146.
   PubMed Web of Science ®Google Scholar
• Mattson MM, Shea TB. 2002. Folate and homocysteine in neural plasticity and neurodegenerative disorders. Trends Neurosci 26:137–146.
   Web of Science ®Google Scholar
• Mihalick SM, Ortiz D, Kumar R, Rogers E, Shea TB. 2004. Folate and vitamin E deficiency impair cognitive performance in mice subjected to oxidative stress: Differential impact on normal mice and mice lacking apolipoprotein E. Neuromol Med 4:197–202.
   Web of Science ®Google Scholar
• Miller AL. 2003. The methionine-homocysteine cycle and its effects on cognitive diseases. Altern Med Rev 8:7–19.
   PubMedGoogle Scholar
• Morrison LD, et al. 1996. Brain S-adenosylmethionine levels are severely decreased in Alzheimer’s disease. J Neurochem 67:1328–1331.
   PubMed Web of Science ®Google Scholar
• Parnetti L, Bottiglierei T, Lowenthal D. 1997. Role ofhomocysteine in age-related vascular and non-vascular disorders. Aging 9:241–257.
   PubMedGoogle Scholar
• Piedrahita JA, Zhang SH, Hagamen JR, Olver PM, Maida N. 1992. Genetics of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc Natl Acad Sci USA 89:4471–4475.
   PubMed Web of Science ®Google Scholar
• Postiglione A, Milan G, Ruocco A, Gallotta G, Guiotto G, Di Minno G. 2001. Plasma folate, vitamin B(12), and total homocysteine and homozygosity for the C677T mutation of the 5,10-methylene tetrahydrofolate reductase gene in patients with Alzheimer’s dementia. A case-control study. Gerontology 47:324–329.
   PubMed Web of Science ®Google Scholar
• Pratico D, Rokach J, Tangirala RK. 1999. Brains of aged apoliprotein E- deficient mice have increased levels ofF2-isoprostanes, in vivo markers of lipid peroxidation. J Neurochem 73:736–741.
   PubMed Web of Science ®Google Scholar
• Ramassamy C, Kryzwkowski P, Averill D, Lussier-Cacan S, Throux L, Christen Y, Davignon J, Poirier J. 2001. Impact of apoE deficiency on oxidative insults and antioxidant levels in the brain. Mol Brain Res 86:76–83.
   PubMedGoogle Scholar
• Ramassamy C, Averill D, Beffert L, Throux L, Lussier-Cacan S, Cohn JS, Christen Y, Schoofs J, Davignon J. 1999. Oxidative damage and protection by antioxidants in the frontal cortex of Alzheimer’s disease is related to the apolipoprotein E genotype. Free Radic Biol Med 27:544–553.
   PubMed Web of Science ®Google Scholar
• Schultz JB, Linddenau J, Seyfried J, Dichgans J. 2000. Glutathione, oxidative stress and neurodegeneration. Eur J Biochem 267:4904–4911.
   PubMedGoogle Scholar
• Selhub J, Miller JW. 1992. The pathogenesis of homocysteinemia, interruption ofthe coordinate regulation by S-adenosylmethionine of theremethylation and transsulfuration of homocysteine. Am J Clin Nutr 55:131–138.
   PubMed Web of Science ®Google Scholar
• Selhub J, Bagley LC, Miller J, Rosenberg IH. 2000. B vitamins, homocysteine, and neurocognitive function in the elderly. Am J Clin Nutr 71(2):614S-620S, February, Review.
   PubMed Web of Science ®Google Scholar
• Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D’Agostino BR, Wilson PW, Wolf PA. 2002. New Eng J Med 346:476–483.
   PubMed Web of Science ®Google Scholar
• Shea TB, Rogers E. 2002b. Folate quenches oxidative damage in brains of apolipoprotein E-deficient mice: Augmentation by vitamin E. Mol Brain Res 108:1–6.
   PubMedGoogle Scholar
• Shea TB, Lyons-Wieler J, Rogers E. 2002a. Homocysteine, folate deprivation and Alzheimer’s disease. J Alz Dis 4:261–267.
   PubMedGoogle Scholar
• Shea TB, Rogers E, Ortiz D, Sheu M-S. 2002b. Apolipoprotein E deficiency promotes increased oxidative stress and compensatory increases in antioxidants in brain tissue. Free Radic Biol Med 33:1115–1120.
   PubMed Web of Science ®Google Scholar
• Shea TB, Ortiz D, Rogers E. 2004. Differential susceptibility of transgenic mice lacking one or both apolipoprotein alleles to folate and vitamin E deprivation. J Alz Dis 6:269–273.
   PubMed Web of Science ®Google Scholar
• Shields DC, et al. 1999. The “thermolabile” variant of methylene- tetrahydrofolate reductase and neural tube defects: An evaluation of genetic risk and the relative importance of the genotypes ofthe embryo and the mother. AmJHum Genet 64:1045–1055.
   Web of Science ®Google Scholar
• Singhal RP, Mays-Hoopes LL, Eichhorn GL. 1987. DNA methylation in aging of mice. Mech Ageing Dev 41:199–210.
   PubMed Web of Science ®Google Scholar
• St George-Hyslop P, Crapper McLachlan D, Tuda T, Rogaev E, Karlinsky H, Lippa C, Pollen D. 1994. Alzheimer’s disease and possible gene interaction. Science 263:537.
   PubMed Web of Science ®Google Scholar
• Stern LL, et al. 2000. Genomic DNA hypomethylation, a characteristic of most cancers, is present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphism in the methylenetetrahydrofolate reductase gene. Cancer Epidemiol Biomarkers Prev 9:849–853.
   PubMed Web of Science ®Google Scholar
• Stover PJ. 2004. Physiology of folate and vitamin B12 in health and disease. Nutr Rev 62:S3–S12.
   PubMed Web of Science ®Google Scholar
• Surtees R, Leonard J, Austin S. 1991. Association of demyelination with deficiency of cerebrospinal-fluid S-adenosylmethionine in inborn errors of methyl-transfer pathway. Lancet 338: 1550–1554.
   PubMed Web of Science ®Google Scholar
• Tchantchou F, Graves M, Ashline D, Morin A, Pimenta A, Ortiz D, Rogers E, Shea TB. 2004. Increased transcription and activity of glutathionesynthase in response to deficiencies in folate, vitamin E and apolipoprotein E. J Neurosci Res 75(4):508–515.
   PubMed Web of Science ®Google Scholar
• Trolin CG, Lofberg C, Trolin G, Oreland L. 1994. Brain ATP:L-methioinine S-adenosyltransferase, S-adenosyl- methioine and S-adenosylhomocysteine: Regional distribution and age-related changes. Eur Neuropsychopharm 4: 469–477.
   PubMed Web of Science ®Google Scholar
• Watkins D, Rosenblatt DS. 1989. Functional methionine synthase deficiency (cb1E and cb1G), clinical and biochemical heterogeneity. Am J Med Genet 34:427–434.
   PubMed Web of Science ®Google Scholar
• Whalley LJ, Starr JM, Deary IJ. 2004. Diet and dementia. J Br Menopause Soc 10:113–117.
   PubMedGoogle Scholar